(Source: iPharma Pharmacy, 2026) A 2026 systematic review and meta-analysis (Prospero CRD42024535096) searched Cochrane Library, EMBASE, and Medline through September 2024, identifying 9,654 studies and including 11 randomized controlled trials comparing GLP-1 receptor agonists against no treatment, placebo, lifestyle intervention, oral contraceptives, anti-androgens, or metformin in PCOS patients
As the body doesnt make B12 or store it for a long time, supplementation may be required for those at risk of deficiency
To do this naturally, our body produces GHRH
The full scope at Ascend includes: Obesity and overweight with comorbidities - full workup, GLP-1 candidacy assessment, lifestyle integration Type 2 diabetes with weight management goals - GLP-1 medications often address both indications simultaneously Hypertension tied to weight - coordinated medication review and lifestyle work Dyslipidemia and metabolic syndrome - lipids often improve markedly with weight loss Prediabetes - HbA1c 5.7-6.4% range, where intervention can prevent progression Fatty liver disease (MASLD) - weight loss is the primary intervention
My advanced training includes IV therapy, aesthetic injectables, lasers, hormone replacement therapy (HRT), PICC placements, and conscious sedation, I am passionate about helping patients feel confident, healthy, and balanced inside and out
Slows gastric emptying, prolonging fullness and reducing appetite